Calithera Biosciences
CALA
CALA was delisted on the 1st of February, 2023.
39 hedge funds and large institutions have $143M invested in Calithera Biosciences in 2015 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 11 increasing their positions, 12 reducing their positions, and 5 closing their positions.
100% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 5
15% more funds holding
Funds holding: 34 → 39 (+5)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
8% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 12
2.22% less ownership
Funds ownership: 52.2% → 49.98% (-2.2%)
40% less capital inflows, than outflows
Capital inflows: $11.1M | Capital outflows: $18.4M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EverPoint Asset Management
Stamford,
Connecticut
|
+$3.62M |
| 2 |
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$3.38M |
| 3 |
EcoR1 Capital
San Francisco,
California
|
+$1.67M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$763K |
| 5 |
Fred Alger Management
New York
|
+$378K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
-$10.2M |
| 2 |
Millennium Management
New York
|
-$4.59M |
| 3 |
New Leaf Venture Partners
New York
|
-$1.22M |
| 4 |
EAM Investors
Solana Beach,
California
|
-$790K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$491K |
CALA Hedge Fund Activity: Q1 2015 in Review
39 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences (CALA) for Q1 2015, worth a combined $143M — down 24% from $189M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new CALA positions and 5 closed out — a net gain of 5 holders — while 11 added to existing stakes and 12 trimmed.
The largest buyer was EverPoint Asset Management, opening a new position worth an estimated $3.62M. The largest seller was Jennison Associates, cutting an estimated $10.2M.
- 39 institutional investors held Calithera Biosciences (CALA) as of Q1 2015, up from 34 in Q4 2014.
- Funds reported $143M of Calithera Biosciences stock for Q1 2015, down 24% quarter-over-quarter.
- 10 funds opened new Calithera Biosciences positions in Q1 2015 and 5 closed out, a net change of +5 holders.
- The largest Calithera Biosciences buyer in Q1 2015 was EverPoint Asset Management, an estimated $3.62M added.
- The largest Calithera Biosciences seller in Q1 2015 was Jennison Associates, an estimated $10.2M sold.
Based on aggregated 13F filings for Q1 2015.